Correlation between disease severity and quality of life index in psoriasis patients treated with Lactobacillus plantarum IS-10506

Menul Ayu Umborowati; Almira Syamsuri; Anang Endaryanto; Ingrid S. Surono; Hok Bing Thio; Cita Rosita Sigit Prakoeswa

doi:10.53730/ijhs.v6nS9.12957

Authors

Menul Ayu Umborowati Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Indonesia, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Almira Syamsuri Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Anang Endaryanto Department of Pediatrics, Faculty of Medicine Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Ingrid S. Surono Faculty of Engineering, Food Technology Department, Bina Nusantara University, Jakarta, Indonesia
Hok Bing Thio Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherland
Cita Rosita Sigit Prakoeswa
cita-rosita@fk.unair.ac.id
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

Keywords:

Psoriasis, Disease severity, Quality of life, Probiotic, Therapy

Abstract

Psoriasis is a chronic and relapsing inflammatory skin disease that affects both genders at all ages. The purpose of this study is to identify the correlation between psoriasis area severity index (PASI) and Dermatology Life Quality Index (DLQI) for patients with plaque psoriasis before and after treatment with Lactobacillus plantarum IS-10506. This was a before after cohort study. Adults with mild to moderate psoriasis were recruited into the study. All participants received the original Indonesian probiotic strain Lactobacillus plantarum IS-10506 at a dose of 2x10¹⁰ colony forming units (CFU) per day for six weeks. A total of 22 patients, with a mean age of 43 years, participated in the study. Participants had psoriasis for an average of 14 years. There was a correlation between PASI score and several quality-of-life questionnaire elements in certain condition, such as professional jobs, unemployment, obesity, and joint symptoms. The correlation between particular conditions reveals that occupations, obesity, and joint symptoms have a greater impact on psoriasis patients.

Downloads

Download data is not yet available.

References

Bahmer, J., & Bahmer, F. (2011). Psoriasis, Addiction, and Personality. Archives of Dermatology, 147, 988. https://doi.org/10.1001/archdermatol.2011.223

Basavaraj, K. H., Navya, M. A., & Rashmi, R. (2011). Stress and quality of life in psoriasis: An update: Stress and psoriasis. International Journal of Dermatology, 50(7), 783–792. https://doi.org/10.1111/j.1365-4632.2010.04844.x

Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008). The Dermatology Life Quality Index 1994-2007: A comprehensive review of validation data and clinical results. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2008.08832.x

Bhosle, M. J., Kulkarni, A., Feldman, S. R., & Balkrishnan, R. (2006). Quality of life in patients with psoriasis. Health and Quality of Life Outcomes, 4(1), 35. https://doi.org/10.1186/1477-7525-4-35

Çakmur, H., & Derviş, E. (2015). The relationship between quality of life and the severity of psoriasis in Turkey. European Journal of Dermatology, 25(2), 169–176. https://doi.org/10.1684/ejd.2014.2511

Chen’, Y.-T. C. T.-J., Chen’, P.-C. L. Y.-C., Chen, Y.-J., Jih’, Y.-L. H.-J.-S., & Chen’, C.-C. (2009). Epidemiological Study of Psoriasis in the National Health Insurance Database in Taiwan. 6.

Choi, J., & Koo, J. Y. M. (2003). Quality of life issues in psoriasis. Journal of the American Academy of Dermatology, 49(2), 57–61. https://doi.org/10.1016/S0190-9622(03)01136-8

da Silva, M. F. P., Fortes, M. R. P., Miot, L. D. B., & Marques, S. A. (2013). Psoríase: Correlação entre gravidade clínica (PASI) e qualidade de vida (DLQI) em pacientes avaliados antes e depois de tratamento sistêmico. Anais Brasileiros de Dermatologia, 88(5), 760–763. https://doi.org/10.1590/abd1806-4841.20132052

Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210–216. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Fransiska, A., Surya Husada, M., & Effendy, E. (2018). The differences of depressive symptoms by gender in people with psoriasis. Asian Journal of Pharmaceutical and Clinical Research, 11(Special Issue 1), 42–45. https://doi.org/10.22159/ajpcr.2018.v11s1.26564

GA, M., L, A., & ASB, M. (2004). Validation of life quality questionnaires for psoriasis patients. An Bras Dermatol, 79, 521–535.

Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004). Determinants of quality of life in patients with psoriasis: A study from the US population. Journal of the American Academy of Dermatology, 51(5), 704–708. https://doi.org/10.1016/j.jaad.2004.04.014

Gudjonsson, J. E., & Elder, J. T. (2019). Psoriasis. In S. Kang, M. Amagai, A. Bruckner, A. Enk, D. Margolis, A. McMichael, & J. Orringer (Eds.), Fitzpatrick’s dermatology in general medicine (9th ed, pp. 457–497). McGraw Hill.

Imafuku, S., Zheng, M., Tada, Y., Zhang, X., Theng, C., Thevarajah, S., Zhao, Y., & Song, H. J. (2018). Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. The Journal of Dermatology, 45(7), 805–811. https://doi.org/10.1111/1346-8138.14338

Khoury, L. R., Danielsen, P. L., & Skiveren, J. (2014). Body image altered by psoriasis. A study based on individual interviews and a model for body image. Journal of Dermatological Treatment, 25(1), 2–7. https://doi.org/10.3109/09546634.2012.739278

Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005). The Psychosocial Burden of Psoriasis: American Journal of Clinical Dermatology, 6(6), 383–392. https://doi.org/10.2165/00128071-200506060-00005

Lambert, J., Hansen, J. B., Sohrt, A., & Puig, L. (2021). Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab. Dermatology and Therapy, 11(4), 1265–1275. https://doi.org/10.1007/s13555-021-00545-5

Lee, Y. W., Park, E. J., Kwon, I. H., Kim, K. H., & Kim, K. J. (2010). Impact of Psoriasis on Quality of Life: Relationship between Clinical Response to Therapy and Change in Health-related Quality of Life. Annals of Dermatology, 22(4), 389. https://doi.org/10.5021/ad.2010.22.4.389

Leino, M., Mustonen, A., Mattila, K., Koulu, L., & Tuominen, R. (2014). Perceived impact of psoriasis on leisure-time activities. European Journal of Dermatology, 24(2), 224–228. https://doi.org/10.1684/ejd.2014.2282

Lin, T.-Y., See, L.-C., Shen, Y.-M., Liang, C.-Y., Chang, H.-N., & Lin, Y.-K. (2011). Quality of Life in Patients with Psoriasis in Northern Taiwan. 34(2), 11.

Lipowska, M., & Lipowski, M. (2015). Narcissism as a Moderator of Satisfaction with Body Image in Young Women with Extreme Underweight and Obesity. PLOS ONE, 10(5), e0126724. https://doi.org/10.1371/journal.pone.0126724

Mabuchi, T., Yamaoka, H., Kojima, T., Ikoma, N., Akasaka, E., & Ozawa, A. (2012). Psoriasis Affects Patientʼs Quality of Life More Seriously in Female than in Male in Japan. 5.

Naldi, L. (2010). Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clinics in Dermatology, 28(1), 67–72. https://doi.org/10.1016/j.clindermatol.2009.03.001

Nayak, P., Girisha, B., & Noronha, T. (2018). Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatology Online Journal, 9(3), 165. https://doi.org/10.4103/idoj.IDOJ_250_17

Nazik, H., Nazik, S., & Gul, F. (2017). Body image, self-esteem, and quality of life in patients with psoriasis. Indian Dermatology Online Journal, 8(5), 343. https://doi.org/10.4103/idoj.IDOJ_503_15

Organization, W. H. (2016). Global Report on Psoriasis. WHO Press, 978, 48.

Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013). Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. Journal of Investigative Dermatology, 133(2), 377–385. https://doi.org/10.1038/jid.2012.339

Prakoeswa, C. R. S., Bonita, L., Karim, A., Herwanto, N., Umborowati, M. A., Setyaningrum, T., Hidayati, A. N., & Surono, I. S. (2022). Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: A randomized controlled trial. Journal of Dermatological Treatment, 33(3), 1491–1498. https://doi.org/10.1080/09546634.2020.1836310

Prameswari, R., Astari, L., Hidayati, A. N., & Prakoeswa, C. R. S. (2017). Efek Lactobacillus plantarum terhadap Imunoglobulin E Serum Total dan Indeks Scoring Atopic Dermatitis (SCORAD) Pasien Dermatitis Atopik Anak. 8.

Rahmatina. (2012). Uji Validitas Dan Reliabilitas Dermatology Life Quality Index (Dlqi) Berbahasa Indonesia Pada Pasien Poliklinik Ilmu Kesehatan Kulit Dan Kelamin Rumah Sakit Dr. Cipto Mangunkusumo. Fakultas Kedokteran Universitas Indonesia Program Pendidikan Dokter Spesialis Ilmu Kesehatan Kulit Dan Kelamin, 5–34.

Rahmayanti, N. D., Hidayati, A. N., Ervianti, E., & Muhdi, N. (2019). Association of psoriasis severity degree with self- esteem, depression and dermatology life quality index. 11.

Revicki, D. A., Willian, M. K., Menter, A., Saurat, J.-H., Harnam, N., & Kaul, M. (2008). Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis. Dermatology, 216(3), 260–270. https://doi.org/10.1159/000113150

Rosen, C. F., Mussani, F., Chandran, V., Eder, L., Thavaneswaran, A., & Gladman, D. D. (2012). Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology, 51(3), 571–576. https://doi.org/10.1093/rheumatology/ker365

Sampogna, F., Tabolli, S., & Abeni, D. (2012). Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life. Acta Dermato Venereologica, 92(3), 299–303. https://doi.org/10.2340/00015555-1273

Sendrasoa, F. A., Razanakoto, N. H., Ratovonjanahary, V., Raharolahy, O., Ranaivo, I. M., Andrianarison, M., Rakotoarisaona, M. F., Rakotonaivo, N. A., Sata, M., Ramarozatovo, L. S., & Rapelanoro, R. F. (2020). Quality of Life in Patients with Psoriasis Seen in the Department of Dermatology, Antananarivo, Madagascar. BioMed Research International, 2020, 1–5. https://doi.org/10.1155/2020/9292163

Setyowatie, L., Sukanto, H., & Murtiastutik, D. (2016). C-Reactive Protein pada Berbagai Derajat Keparahan Psoriasis Vulgaris (C-Reactive Protein in Various Degrees Severity of Psoriasis Vulgaris). 28(2), 9.

Silva, M. F. P. da, Fortes, M. R. P., Miot, L. D. B., & Marques, S. A. (2013). Psoriasis: Correlation between severity index (PASI) and systemic treatment. Anais Brasileiros de Dermatologia, 88(5), 760–763. https://doi.org/10.1590/abd1806-4841.20132052

Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D., Finlay, A. Y., Grifitths, C. E. M., Jackson, K., McHugh, N. J., McKenna, K. E., Reynolds, N. J., Ormerod, A. D., & Chair of Guideline Group). (2005). British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005: Biological interventions for psoriasis. British Journal of Dermatology, 153(3), 486–497. https://doi.org/10.1111/j.1365-2133.2005.06893.x

Surono, I. S. (2003). In Vitro Probiotic Properties of Indigenous Dadih Lactic Acid Bacteriaa. 6.

Thio, H. B. (2018). The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective. The Journal of Rheumatology, 94, 30–31. https://doi.org/10.3899/jrheum.180133

Timotijević, Z. S., Majcan, P., Trajković, G., Relić, M., Novaković, T., Mirković, M., Djurić, S., Nikolić, S., Lazić, B., & Janković, S. (2017). The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis. ACTA DERMATOVENEROLOGICA CROATICA, 8.

Umborowati, M. A., Damayanti, D., Anggraeni, S., Endaryanto, A., Surono, I. S., Effendy, I., & Prakoeswa, C. R. S. (2022). The role of probiotics in the treatment of adult atopic dermatitis: A meta-analysis of randomized controlled trials. Journal of Health, Population and Nutrition, 41(1), 37. https://doi.org/10.1186/s41043-022-00318-6

Valenzuela, F. (2011). Epidemiology and Quality of Life of Patients With Psoriasis in Chile. 7.

Yeroushalmi, S., Hakimi, M., Chung, M., Bartholomew, E., Bhutani, T., & Liao, W. (2022). Psoriasis and Exercise: A Review. Psoriasis: Targets and Therapy, Volume 12, 189–197. https://doi.org/10.2147/PTT.S349791

Yip, S. Y. (1984). The prevalence of psoriasis in the Mongoloid race. 4.

Zachariae, H., Zachariae, R., Blomqvist, K., Davidsson, S., Molin, L., Mørk, C., & Sigurgeirsson, B. (2002). Quality of Life and Prevalence of Arthritis Reported by 5,795 Members of the Nordic Psoriasis Associations. Acta Derm Venereol, 7.